VitroScreen m-Dermis (scaffold free organoid) is produced by human primary dermal fibroblasts and with donors of different age : it has shown interesting features during 21 days in culture conditions.
By precisely mimicking ECM production in vivo, the micro-dermis model resulted to be an unique and innovative tool for active ingredients screening on dermal matrix deposition and remodeling by VitroScreen Multiple Endpoints Approach that includes also 3D imaging techniques.
Marisa Méloni
marisa.meloni@vitroscreen.com
Via Mosé Bianchi,103
20149 Milano
LIVE & HYBRID All you need to know about preclinical and clinical testing is at…
👉 Register: Exclusive webinar in English April 28th 2025 at 3:00 PM [CEST] We…
HOW AI IS SHAPING BIO-BASED BEAUTY AND PERSONALIZED PRODUCTS 📆 May, 8th 2025 ⏱️ 16:00…